Tectonic Therapeutic, Inc.
6.30%
657,976
1681087
878972108
Apr 2, 2025
Apr 7, 2025, 05:19 PM
Reporting Persons (8)
This is a joint filing. The reported shares may overlap between reporting persons and should not be summed.
| Name | Type | % of Class | Aggregate | Sole Voting | Shared Voting |
|---|---|---|---|---|---|
| Terrance McGuire | Individual | 6.30% | 657,976 | 0 | 657,976 |
| Polaris Partners IX, L.P. | Partnership | 3.10% | 573,062 | 0 | 573,062 |
| Polaris Partners GP IX, L.L.C. | Other | 3.10% | 573,062 | 0 | 573,062 |
| Jonathan Flint | Individual | 0.50% | 84,914 | 0 | 84,914 |
| Polaris Founders Capital Fund II, L.P. | Partnership | 0.30% | 64,652 | 0 | 64,652 |
| Polaris Founders Capital Fund Management Co. II, L.L.C. | Other | 0.30% | 64,652 | 0 | 64,652 |
| Polaris Founders Capital Fund Management Co. I, L.L.C. | Other | 0.10% | 20,262 | 0 | 20,262 |
| Polaris Founders Capital Fund I, L.P. | Partnership | 0.10% | 20,262 | 0 | 20,262 |
Disclosure Items (2)
Common Stock, $0.0001 par value per share
Tectonic Therapeutic, Inc.
490 Arsenal Way, Watertown, MA, 02472
See Items 7-11 and 13 of the cover pages of this Amendment for each Reporting Person and the corresponding comments.
See Items 7-11 and 13 of the cover pages of this Amendment for each Reporting Person and the corresponding comments.
On April 3, 2025, PP IX entered into Stock Purchase Agreements with each of Timothy A. Springer ("Dr. Springer") and TAS Partners LLC ("TAS"), pursuant to which Dr. Springer purchased 87,500 shares of Common Stock from PP IX at a purchase price of $17.10 per share, or $1,496,250 in the aggregate, and TAS purchased 412,500 shares of Common Stock at a purchase price of $17.10 per share, or $7,053,750 in the aggregate. The closing occurred on April 7, 2025.
April 7, 2025